Medicare Part D provides prescription drug coverage through private insurance companies approved by Medicare. In 2026, the program has reached a historic milestone with the full implementation of the $2,100 out-of-pocket cap, designed to protect enrollees from catastrophic drug costs.

The 2026 Out-of-Pocket Cap

For the first time in the history of the program, there is a “hard cap” on what you pay for your medications.

  • The Limit: Once you spend $2,100 on out-of-pocket costs for covered drugs in 2026, you pay $0 for the remainder of the year.
  • What Counts: Your deductible, copayments, and coinsurance all count toward this $2,100 limit.
  • What Does Not Count: Monthly premiums and the cost of drugs not covered by your specific plan’s formulary do not count toward the cap.
  • Inflation Adjustment: This limit is $100 higher than the 2025 cap, reflecting a standard annual adjustment based on drug spending trends.

2026 Standard Benefit Structure

While every private plan is different, the “standard” benefit for 2026 follows a three-phase model:

  • Phase 1: Deductible: You pay 100% of your drug costs until you hit the deductible, which is capped at $615 in 2026.
  • Phase 2: Initial Coverage: You typically pay 25% of the cost of your drugs until your total out-of-pocket spending reaches the $2,100 threshold.
  • Phase 3: Catastrophic Coverage: Once you hit the $2,100 cap, you enter this final phase where your cost-sharing drops to $0 for all covered Part D drugs.

Medicare Prescription Payment Plan

Introduced recently and enhanced for 2026, this voluntary program allows you to spread your out-of-pocket costs over the course of the year.

  • Monthly Billing: Instead of paying a large amount at the pharmacy counter (for example, if you hit your $2,100 cap in January), your plan bills you in monthly installments.
  • Automatic Renewal: New for 2026, if you opted into this payment plan in 2025, your participation will automatically renew unless you choose to opt out.
  • Cost: There is no extra fee to use this payment option, and it does not change the total amount you owe; it simply helps with household budgeting.

Lower Prices on Negotiated Drugs

A major feature of 2026 is the debut of “Maximum Fair Prices” for 10 of the most expensive and commonly used drugs in the Part D program. These prices were negotiated directly between the federal government and drug manufacturers.

  • The Drugs: This list includes widely used medications such as Eliquis, Jardiance, Xarelto, Januvia, and Farxiga.
  • The Savings: On average, the out-of-pocket costs for these 10 drugs are expected to decline by approximately 50 percent compared to 2025 prices, helping more seniors stay below the $2,100 cap for longer.

Part D Premiums and IRMAA

While the average monthly premium for a standalone Part D plan is approximately $34.50 in 2026, high earners may pay an additional surcharge.

  • Standard Premium: Varies by plan, though many Medicare Advantage plans include Part D coverage for $0.
  • Part D IRMAA: If your 2024 income was above $109,000 (individual) or $218,000 (joint), you will pay an extra monthly amount ranging from $14.50 to $83.30 in 2026.
  • Vaccine Coverage: All vaccines recommended by the Advisory Committee on Immunization Practices (ACIP), including the shingles and RSV vaccines, remain available for $0 with no deductible or copay.

Source: Medicare.gov, “Medicare and You Handbook 2026”; and KFF, “A Current Snapshot of the Medicare Part D Prescription Drug Benefit” (2026 Update).